cytosine has been researched along with Keratoconjunctivitis in 7 studies
Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.
Excerpt | Relevance | Reference |
---|---|---|
"2% cidofovir eyedrops and 1% cyclosporine eyedrops administered 4 times daily (qid) to treat acute adenoviral keratoconjunctivitis." | 9.09 | Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. ( Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R, 2001) |
"2% cidofovir eyedrops and 1% cyclosporine eyedrops administered 4 times daily (qid) to treat acute adenoviral keratoconjunctivitis." | 5.09 | Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. ( Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R, 2001) |
" Further clinical studies to find an efficacious yet tolerable dosage regimen of cidofovir, possibly using an improved pharmaceutical preparation, are required." | 2.70 | The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. ( Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Hanaoka, N | 1 |
Hazama, M | 1 |
Fukushima, K | 1 |
Fujimoto, T | 1 |
Nwanegbo, EC | 1 |
Romanowski, EG | 3 |
Gordon, YJ | 3 |
Gambotto, A | 1 |
Araullo-Cruz, T | 1 |
Hillenkamp, J | 2 |
Reinhard, T | 2 |
Ross, RS | 2 |
Böhringer, D | 2 |
Cartsburg, O | 2 |
Roggendorf, M | 2 |
De Clercq, E | 2 |
Godehardt, E | 2 |
Sundmacher, R | 2 |
Segal, E | 1 |
Romano, A | 1 |
Eylan, E | 1 |
Stein, R | 1 |
2 trials available for cytosine and Keratoconjunctivitis
Article | Year |
---|---|
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Ag | 2001 |
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; An | 2002 |
5 other studies available for cytosine and Keratoconjunctivitis
Article | Year |
---|---|
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir.
Topics: Adenoviridae Infections; Adenovirus Infections, Human; Cystitis; Cytosine; Humans; Immunocompromised | 2022 |
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agent | 2007 |
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye In | 1994 |
Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agent | 2000 |
Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
Topics: Animals; Candida; Candidiasis; Conjunctivitis; Corneal Ulcer; Cytosine; Drug Resistance, Microbial; | 1975 |